Results 251 to 260 of about 600,406 (349)

Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Rheumatoid arthritis is a complex systemic disorder characterised primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease e.g. of the lung with potentially devastating clinical consequences.
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

Trends in Mortality Due to Coexisting Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease in the United States, 1999-2020: A Retrospective Observational Study. [PDF]

JRSM Cardiovasc Dis
Shaikh RH, Shahabi M, Jamshed MM, Ishfaq H, Hussain K, Azeem N, Faheem O.   +6 more
europepmc   +1 more source

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE

, 2009
А. Н. Закирова, Oganov Rg, Н. Э. Закирова, Г. Р. Клочкова, Ф. С. Мусина   +4 more
openalex   +2 more sources

Correction: Outdoor air pollution and hospitalizations for ischemic heart disease: a systematic review and meta-analysis. [PDF]

Front Public Health
Maimaitiniyazi M, Haibier A, Maimaitiniyazi M, Maisuti M, Aihaiti A, Yisimiti T, Nijiati M.   +6 more
europepmc   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

The crosstalk of breast cancer and ischemic heart disease. [PDF]

Cell Death Discov
Luo Y, Liu J, Qu P, Han S, Li X, Wang Y, Su X, Zeng J, Li J, Deng S, Liang Q, Hou L, Cheng P.   +12 more
europepmc   +1 more source

DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE

, 2015
S. А. Shalnova, А. Д. Деев, S. А. Boytsov   +2 more
openalex   +2 more sources

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source